BioSpace News Archive

Biotech Beach

Kura Oncology to Participate in Stifel Targeted Oncology Days

Kura Oncology, Inc. today announced its participation in Stifel 2023 Targeted Oncology Days. Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at 1:00 p.m. ET / 10:00 a.m. PT on April 25, 2023.

April 18, 2023

·

1 min read

Business

Repligen to Report First Quarter 2023 Financial Results

Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2023 financial results on Tuesday, May 2, 2023.

April 18, 2023

·

2 min read

Deals

Coeptis Therapeutics Signs Agreement to Acquire Allogeneic Immuno-Oncology NK Platform in Phase 1 Clinical Trials from Deverra Therapeutics

Coeptis Therapeutics Holdings, Inc. announced it has entered into a binding term sheet with Deverra Therapeutics, Inc. (“Deverra Therapeutics”) pursuant to which it has obtained an exclusive right, until August 31, 2023.

April 18, 2023

·

8 min read

Biotech Beach

Arrowhead Pharmaceuticals to Webcast Fiscal 2023 Second Quarter Results

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on May 2, 2023, at 4:30 p.m. ET to discuss its financial results for the fiscal 2023 second quarter ended March 31, 2023.

April 18, 2023

·

4 min read

Genetown

ProQR Announces Annual Meeting of Shareholders to be Held May 17, 2023

ProQR Therapeutics NV. announced the Annual General Meeting of Shareholders will take place on Wednesday, May 17, 2023 at 16:00 CET at the offices of Allen & Overy LLP, in Amsterdam, the Netherlands.

April 18, 2023

·

6 min read

Business

Rhythm Pharmaceuticals to Report First Quarter 2023 Financial Results on Tuesday, May 2, 2023

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, May 2, 2023 to report its first quarter 2023 financial results and provide a corporate update.

April 18, 2023

·

8 min read

Business

Science 37 Adds New Head of Quality, Irena Lambridis

Science 37 Holdings, Inc., the industry-leading Metasite™, announced the appointment of Irena Lambridis as its Global Head of Quality Assurance & Compliance.

April 18, 2023

·

5 min read

Biotech Beach

Arcutis Announces FDA Acceptance of New Drug Application for Roflumilast Foam 0.3% for the Treatment of Seborrheic Dermatitis in Individuals Aged 9 Years and Older

Arcutis Biotherapeutics, Inc. today announced the U.S. Food and Drug Administration (FDA) has accepted for review the company’s new drug application (NDA) for roflumilast foam 0.3% for the treatment of seborrheic dermatitis in individuals 9 years of age and older.

April 18, 2023

·

7 min read

Biotech Bay

NEUSPERA MEDICAL® ANNOUNCES FDA CLEARANCE OF ITS SYSTEM FOR PERIPHERAL NERVE STIMULATION

Neuspera® Medical, a medical device company developing implantable devices for patients battling chronic illnesses, today announced it received U.S. Food and Drug Administration (FDA) clearance for the next-generation Neuspera ultra-miniaturized system.

April 18, 2023

·

2 min read

Genetown

Corbus Pharmaceuticals Hosting Virtual ‘Meet the Expert’ Series: Blocking TGFβ with CRB-601--a New Play for an Old Target

Corbus Pharmaceuticals Holdings, Inc., a precision oncology company, announced that the Company will host the first in the series of virtual ‘Meet the Expert’ events titled Blocking TGFβ with CRB-601—a New Play for an Old Target, on April 25th at 11:00 AM ET.

April 18, 2023

·

3 min read